Sander Markx from Columbia University: Charting a New Future in Targeted Psychiatric Care

MAY 25, 2016
Adam Hochron

Studying the use of targeted medicines in psychiatry is still new but early studies have shown that this could be a viable treatment option in the future for some patients in need.

While most medications to treat psychiatric conditions are meant to address patient symptoms they are not all directed toward a cure for the respective conditions. Although he was not ready to say that targeted therapies could provide a cure for some of these conditions and patients Sander Markx, MD, from Columbia University said there is evidence that this field could provide a new level of treatment not seen in current traditional patient care. 

Related Coverage >>>
Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.